Bausch+Lomb Results Presentation Deck slide image

Bausch+Lomb Results Presentation Deck

4Q22 Financial Highlights & Segment Drivers Total Company Revenue Millions USD 1,001 54 947 4Q21 FX Impact¹ 996 4Q22 +5% organic revenue ¹,² growth Seventh consecutive quarter of organic revenue growth 1,2 BAUSCH + LOMB Second consecutive quarter of organic revenue growth across all three segments 1,2 China saw shift towards positive signs of economic recovery following policy adjustments in the middle of the 4Q22 . 65% . Vision Care $626M Consumer 35% Contact Lens 4 Q 22 +5% Strong demand for key franchises: Lumify® (+25% reported revenue growth) Ocuvite® PreserVision® (+13% reported revenue growth) Daily SiHy (+85% reported revenue growth) Bausch+Lomb ULTRA® (+2% reported revenue growth) Surgical 53% $188M 27% 20% ■ Implantables ■ Equipment Consumables/Other ORGANIC REVENUE +4% Growth in implantables (+2% reported revenue growth; +13% organic revenue growth ¹.2), driven by premium and standard IOLS Strong demand for consumables (5% reported revenue decline; 3% organic revenue growth ¹.2), driven by an increase in cataract and retina procedures Equipment impacted by supply availability Ophthalmic Pharmaceuticals 61% $182M U.S. CHANGE 1,2 39% International +7% • Vyzulta® saw ~-18% TRx growth³ in 4Q22; continued geo-expansion 1. This is a non-GAAP measure or ratio. See Slide 2 and Appendix for further information on non-GAAP measures and ratios. 2. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. 3. IQVIA NPA monthly. U.S. only. 4. FX impact is determined by comparing 2022 reported amounts adjusted to exclude currency impact, calculated using 2021 monthly average exchange rates, to the actual 2021 reported amounts. • Positive early stages of XIPERE® launch. • COVID recovery in China impacted International portfolio • Capitalized on competitor supply challenges to drive U.S. Gx growth 9
View entire presentation